Kiener Peter A
Insider CIK 1328146 · SCMP Chief Scientific Officer · PIRS Director · CUE Director · LVTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| LVTX LAVA Therapeutics NV | D To issuer deriv | 2025-11-13 | 2025-11-17 | 33,390 | — | $0 | 0 | SEC↗ |
| LVTX LAVA Therapeutics NV | A Award deriv | 2025-02-13 | 2025-02-18 | 33,390 | — | $0 | 33,390 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2023-06-21 | 2023-06-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2023-03-23 | 2023-03-27 | 9,682 | — | $0 | 96,062 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2023-03-23 | 2023-03-27 | 9,325 | $3.28 | $30.6K | 357 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2023-03-23 | 2023-03-27 | 9,682 | $2.86 | $27.7K | 9,682 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2022-06-22 | 2022-06-24 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-11-16 | 2021-11-17 | 1,361 | — | $0 | 105,744 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-11-16 | 2021-11-17 | 1,361 | $2.86 | $3.9K | 1,361 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2021-11-16 | 2021-11-17 | 1,361 | $18.02 | $24.5K | 0 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2021-11-15 | 2021-11-17 | 18,815 | — | $0 | 107,105 | SEC↗ |
| CUE Cue Biopharma, Inc. | S Sale | 2021-11-15 | 2021-11-17 | 18,815 | $17.92 | $337.2K | 0 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise | 2021-11-15 | 2021-11-17 | 18,815 | $2.86 | $53.8K | 18,815 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2021-06-25 | 2021-06-29 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-06-23 | 2020-06-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2020-01-25 | 2020-01-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2019-01-25 | 2019-01-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 8,000 | — | $0 | 8,000 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | A Award deriv | 2018-10-24 | 2018-10-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | M Exercise deriv | 2018-06-12 | 2018-06-14 | 9,600 | — | $0 | 9,600 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 87,203 | $4.20 | $366.3K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 250,000 | $9.67 | $2.42M | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 38,500 | $3.18 | $122.4K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 133,000 | $6.15 | $818.0K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer | 2018-02-13 | 2018-02-13 | 44,856 | $18.00 | $807.4K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-12-31 | 2018-01-04 | 329 | $9.10 | $3.0K | 44,856 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | F Tax w/h | 2017-12-28 | 2018-01-02 | 27,496 | $17.98 | $494.4K | 44,527 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise deriv | 2017-12-07 | 2017-12-11 | 50,000 | — | $0 | 242,567 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | S Sale | 2017-12-07 | 2017-12-11 | 50,000 | $16.50 | $825.0K | 2,023 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | M Exercise | 2017-12-07 | 2017-12-11 | 50,000 | $8.33 | $416.5K | 52,023 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-09-30 | 2017-10-05 | 330 | $9.10 | $3.0K | 2,023 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-06-30 | 2017-07-07 | 336 | $8.93 | $3.0K | 1,693 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-03-31 | 2017-05-10 | 321 | $9.35 | $3.0K | 1,357 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-03-06 | 2017-03-08 | 133,000 | — | $0 | 626,270 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-03-06 | 2017-03-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-12-31 | 2017-01-06 | 287 | $10.46 | $3.0K | 1,036 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-09-30 | 2016-10-21 | 320 | $9.38 | $3.0K | 749 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-06-30 | 2016-07-18 | 300 | $9.32 | $2.8K | 429 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-03-31 | 2016-06-16 | 129 | $9.29 | $1.2K | 129 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2016-03-02 | 2016-03-04 | 116,270 | — | $0 | 493,270 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2015-03-04 | 2015-03-13 | 77,000 | — | $0 | 377,000 | SEC↗ |